Stock BIO.B BIO-RAD LABORATORIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Bio-Rad Laboratories, Inc. Nyse

Equities

BIO.B

US0905721082

Market Closed - Nyse
Other stock markets
 04:15:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
279.9 USD 0.00% Intraday chart for Bio-Rad Laboratories, Inc. -14.31% -12.71%
May. 08 UBS Adjusts Price Target on Bio-Rad Laboratories to $385 From $420, Maintains Buy Rating MT
May. 08 RBC Adjusts Price Target on Bio-Rad Laboratories to $414 From $420 MT

Chart calendar Bio-Rad Laboratories, Inc.

c02b4.JNmX_HmcXIHClAM9DSHtNt6hQEFzRuw7JyE29UU3G8I.TIbTkSbZaeD20kRqbki3ArLkD3g9HosPX1J_gXV1c4FGiNWVA9YXxa_tQg~e1362f97c77e75a4348144c74c77042d

Upcoming events on Bio-Rad Laboratories, Inc.

2024-05-14 02:05 pm RBC Capital Markets Global Healthcare Conference
2024-07-24 Q2 2024 Earnings Release (Projected)
2024-10-23 Q3 2024 Earnings Release (Projected)
2025-02-12 Q4 2024 Earnings Release (Projected)
2025-04-23 Q1 2025 Earnings Release (Projected)

Past events on Bio-Rad Laboratories, Inc.

2024-05-07 05:00 pm Q1 2024 Earnings Call
2024-05-07 04:15 pm Q1 2024 Earnings Release
2024-04-23 07:00 pm Annual General Meeting
2024-02-29 02:30 pm Citi Unplugged Medtech and Life Sciences Access Day
2024-02-15 05:00 pm Q4 2023 Earnings Call
2024-02-15 04:15 pm Q4 2023 Earnings Release
2024-01-07 JPMorgan Healthcare Conference
2023-10-26 05:00 pm Q3 2023 Earnings Call
2023-10-26 04:15 pm Q3 2023 Earnings Release
2023-09-07 11:00 am Wells Fargo Healthcare Conference
2023-08-03 05:00 pm Q2 2023 Earnings Call
2023-08-03 04:15 pm Q2 2023 Earnings Release
2023-06-08 03:00 pm Jefferies Global Healthcare Conference
2023-05-17 03:35 pm RBC Global Healthcare Conference
2023-05-04 05:00 pm Q1 2023 Earnings Call
2023-05-04 04:15 pm Q1 2023 Earnings Release
2023-04-25 07:00 pm Annual General Meeting
2023-03-02 11:45 am Citi Healthcare Services Medtech Tools & HCIT Conference
2023-02-16 05:00 pm FY 2022 Earnings Call
2023-02-16 04:05 pm FY 2022 Earnings Release

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD		Released
Forecast
Spread 		2 312
2 329
-0.73%		2 546
2 430
4.76%		2 923
2 893
1.04%		2 802
2 816
-0.49%		2 671
2 676
-0.18%
2 661

EBITDA
Million USD		Released
Forecast
Spread 		390
406
-4.12%		537
522
2.96%		677
678
-0.04%		668
635
5.14%		536
521
2.92%
470

EBIT
Million USD		Released
Forecast
Spread 		279
294
-5.39%		427
403
5.8%		571
598
-4.49%		524
530
-1.09%		379
383
-1.13%
347

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		4 908
3 985
23.15%		5 438
694
683.59%		0,00
0,00
- 		-850
503
-269.07%
377

Net income
Million USD		Released
Forecast
Spread 		0,00
0,00
- 		3 806
3 087
23.3%		4 246
541
684.82%		-3 628
-3 508
-3.42%		-637
392
-262.67%
294

EPS
USD		Released
Forecast
Spread 		0,00
0,00
- 		126
102
23.37%		141
17,9
683.94%		0,00
0,00
- 		-21,8
13,5
-262.11%
10,3

Announcement Date13/02/2011/02/2110/02/2216/02/2315/02/24-

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million USD		Released
Forecast
Spread 		733
732
0.11%		700
677
3.48%		691
674
2.6%		681
683
-0.28%		730
741
-1.45%		677
689
-1.8%		681
696
-2.12%		632
692
-8.61%		681
687
-0.79%		611
620
-1.5%
641


669


733


649

EBITDA
Million USD		Released
Forecast
Spread 		140
140
0.06%		179
138
30.25%		156
135
16.12%		132
140
-5.26%		156
167
-6.51%		149
151
-1.79%		138
134
2.51%		113
143
-21.03%		137
136
0.61%		109
91,3
18.86%
93,0


119


155


114

EBIT
Million USD		Released
Forecast
Spread 		113
108
4.14%		154
109
41.6%		130
106
23.09%		106
111
-4.46%		127
140
-9.16%		84,2
122
-31.13%		108
106
2.07%		81,6
112
-27.14%		105
107
-1.39%		59,0
61,8
-4.48%
64,9


88,8


122


82,7

Earnings before Tax (EBT)
Million USD		Released
Forecast
Spread

















-1 500
108
-1491.07%




















Net income
Million USD		Released
Forecast
Spread











828
953
-13.17%


-1 162
83,6
-1490.39%


350

















EPS
USD		Released
Forecast
Spread








-5,52
2,63
-309.89%





-39,6
2,81
-1508.9%




















Announcement Date10/02/2228/04/2228/07/2227/10/2216/02/2304/05/2303/08/2326/10/2315/02/2407/05/24----

Upcoming sector events for Bio-Rad Laboratories, Inc.

2024-05-12 PARAMOUNT BED HOLDINGS CO., LTD.: Q4 2023 Earnings Release
2024-05-13 HLB CO., LTD.: Q1 2024 Earnings Release (Projected)
2024-05-13 TERUMO CORPORATION: Q4 2023 Earnings Release
2024-05-13 ALFRESA HOLDINGS CORPORATION: Q4 2023 Earnings Release
2024-05-14 01:00 am AMBU A/S: Q2 2024 Earnings Release
2024-05-14 PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release
2024-05-14 HOYA CORPORATION: Q4 2023 Earnings Release
2024-05-16 02:00 am CONVATEC GROUP PLC: Q1 2024 Sales and Revenue Release - Trading Update
2024-05-22 01:00 am YPSOMED HOLDING AG: Q4 2024 Earnings Release
2024-05-23 06:45 am MEDTRONIC PLC: Q4 2024 Earnings Release
More events

Past sector events for Bio-Rad Laboratories, Inc.

2024-05-10 04:10 pm ATRION CORPORATION: Q1 2024 Earnings Release
2024-05-09 NIPRO CORPORATION: Q4 2023 Earnings Release
2024-05-09 PHC HOLDINGS CORPORATION: Q4 2023 Earnings Release
2024-05-09 04:30 pm METTLER-TOLEDO INTERNATIONAL, INC.: Q1 2024 Earnings Release
2024-05-09 04:03 pm BIOLIFE SOLUTIONS, INC.: Q1 2024 Earnings Release
2024-05-09 04:01 pm INSULET CORPORATION: Q1 2024 Earnings Release
2024-05-09 06:30 am STEVANATO GROUP S.P.A.: Q1 2024 Earnings Release
2024-05-09 06:30 am EMBECTA CORP.: Q2 2024 Earnings Release
2024-05-09 06:00 am HAEMONETICS CORPORATION: Q4 2024 Earnings Release
2024-05-08 POLY MEDICURE LIMITED: Q4 2024 Earnings Release (Projected)

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BIO Stock
  4. BIO.B Stock
  5. Calendar Bio-Rad Laboratories, Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW